Cervical Cancer Screening: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Cervical Cancer Screening

Cervical Cancer Screening represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Cervical Cancer Screening Recommended?

• Routine preventive screening for all women aged 21 to 65 years.

• Women experiencing post-coital (after intercourse) bleeding, intermenstrual spotting, or unusual discharge.

• Abnormal prior Pap smear requiring video colposcopy and high-risk HPV DNA genotyping.

• Women and parents seeking HPV vaccination counseling (Gardasil-9 vaccine).

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Clinical Gynaecological Exam

Gentle speculum examination by Dr. Neha Gupta ensuring complete comfort and privacy.

Step 2: Liquid Cytology & HPV Sampling

Cervical brush collection of cells for Liquid-Based Cytology (LBC) and High-Risk HPV DNA PCR.

Step 3: Video Colposcopy (if indicated)

High-definition Video Colposcopy with acetic acid and Lugol's iodine staining if screening is positive.

Step 4: Pre-Cancer Care or Long-Term Clearance

Immediate outpatient treatment (LEEP/Cryo) for pre-cancerous lesions or regular screening clearance.

Director's Signature Innovation: Preventive Cervical Cancer Screening & HPV Protection

Dr. Neha Gupta leads the Cervical Cancer Prevention & Screening Clinic at Spica Healthcare. Combining High-Risk Human Papillomavirus (HPV DNA PCR testing for oncogenic types 16, 18, 31, 33, 45, 52, 58), Liquid-Based Cytology (LBC ThinPrep Pap smear), and high-definition Video Colposcopy with directed micro-biopsies, precancerous cervical dysplasia (CIN-1, CIN-2, CIN-3) is detected and treated with day-care LEEP/cervical cryotherapy decades before invasive cancer can develop, offering 100% preventable cervical health.

✔ High-Risk HPV DNA Co-Testing: Gold-standard test detecting oncogenic viral DNA years before cellular changes

✔ Liquid-Based Cytology (LBC): Superior specimen quality with automated cell processing and HPV reflex testing

✔ Video Colposcopy & LEEP: Immediate outpatient diagnosis and treatment of pre-cancerous cervical lesions

✔ HPV Vaccination Guidance: Universal vaccination protocols for adolescent girls and adult women up to age 45

Recovery Timeline & Functional Milestones

Phase 1: Same-Day Sample Collection (Day 1)

Gentle 5-minute pelvic examination, liquid-based Pap collection, and HPV DNA sample collection in clinic.

Phase 2: Molecular Lab Results (Day 3 – 5)

Automated liquid cytology and high-risk HPV PCR molecular report review with Dr. Neha Gupta.

Phase 3: Long-Term Preventive Surveillance (Every 3–5 Years)

Clearance certificate and scheduled regular 5-year HPV co-testing interval for ongoing protection.

Frequently Asked Clinical Questions (FAQs)

Why is cervical cancer considered completely preventable?

Cervical cancer is almost 100% preventable because it develops very slowly over 10 to 15 years from persistent High-Risk HPV infection. Regular Pap smear and HPV DNA screening detects the pre-cancerous stage (CIN), allowing simple 15-minute outpatient treatment that stops cancer from ever developing.

How often should a woman undergo cervical cancer screening?

Women aged 21 to 29 should have a Pap smear every 3 years. Women aged 30 to 65 should have HPV DNA testing combined with Pap smear (co-testing) every 5 years, which provides the highest level of protection.

Is Cervical Cancer Screening covered under Ayushman Bharat?

Yes, preventive cervical cancer screening, HPV DNA testing, colposcopies, and LEEP procedures at Grover Hospital Bathinda are covered under PM-JAY Ayushman Bharat and 30+ private insurance TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Cervical Cancer Screening is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.